Cancer news

Latest news, press releases and blog posts from Cancer Research UK.

News Post List

Age: the biggest cancer risk factor

Age is the single biggest risk factor for cancer. We explore why age increases the risk of cancer and what it means.

NHS funding: New money for England is a start, but it must be spent wisely

The new NHS England funding boost from the Prime Minister needs to focus on staff shortages to make a difference in cancer care.

News digest – trial to test lung cancer vaccine, cervical screening language, prostate cancer spit test and AI for the NHS

In this week’s headlines: we launch a new trial testing a lung cancer vaccine and kids in England have already reached their sugar limit for the year.

‘Our NHS is there for us, now it’s time to stand with them’

We've launched a campaign for more NHS staff to diagnose and treat cancer. Cancer survivor Elizabeth Bailey explains how you can get involved.

Cancer Research UK tests first of its kind vaccine to treat lung cancer

A first of its kind treatment vaccine has moved into a phase I clinical trial for patients with non-small cell lung cancer.

News digest – breast and lung cancer immunotherapy, vaping and ASCO highlights

Top stories this week: A breast cancer immunotherapy first and lung cancer immunotherapy approved for NHS use in England.

Cancer Research UK announces new chief business officer

Cancer Research UK has appointed Tony Hickson as the charity’s new chief business officer.

Prostate cancer drug given initial ‘no’ for NHS in England

The prostate cancer drug abiraterone has been provisionally rejected as a first-line treatment on the NHS in England.

Ex-smokers might be better off with high rather than low nicotine e-cigs

Vapers using low rather than high nicotine e-cigarettes may be using their devices more intensely, potentially increasing the risk of exposure to toxins.

Older breast cancer patients in England less likely to survive than in four other European countries

Older women diagnosed with breast cancer in England are less likely to survive their disease than those in Belgium, Poland, Ireland and the Netherlands.

Pages